Company Filing History:
Years Active: 1981-1998
Title: Innovations by David Loebenberg
Introduction
David Loebenberg is an accomplished inventor based in Monsey, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compositions. With a total of three patents to his name, Loebenberg's work has the potential to impact medical treatments significantly.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Lipophilic oligosaccharide antibiotic compositions." This patent describes an aqueous pharmaceutical composition that includes a lipophilic oligosaccharide antibiotic salt, specifically the N-methylglucamine salt of the everninomicin-type antibiotic. The composition also incorporates a binding agent, such as human serum albumin or recombinant human albumin, along with a tonicity agent like mannitol. Another notable patent is for "Lipophilic oligosaccharide antibiotic salt compositions," which further explores the applications of these innovative antibiotic formulations.
Career Highlights
David Loebenberg is currently associated with Schering Corporation, where he continues to advance his research and development efforts. His work at the company has allowed him to focus on creating effective pharmaceutical solutions that address critical health challenges.
Collaborations
Loebenberg has collaborated with notable professionals in his field, including Mahesh G Patel and Vincent P Gullo. These partnerships have contributed to the success of his projects and the advancement of pharmaceutical innovations.
Conclusion
David Loebenberg's contributions to antibiotic compositions highlight his role as a significant inventor in the pharmaceutical industry. His innovative patents and collaborations demonstrate his commitment to improving healthcare solutions.